CD68 in Cerebral Aneurysms of Smokers and Nonsmokers: An Immunohistochemical Analysis

Abstract

Background There is some evidence indicating that inflammation of the aneurysmal wall is related to aneurysmal growth and rupture. The presence of CD68 may indicate greater inflammatory activity. The objective of this study is to evaluate CD68 immunoexpression in surgically resected brain aneurysms and its association with smoking.

Methods The resected brain aneurysmal walls after microsurgical clipping were envoyed to immunohistochemistry investigation. The objective was to evaluate the expression of CD68 and CD34 antibodies. The associations between inflammatory markers, smoking, and rupture were tested using Fischer's exact test.

Results CD68 immunoexpression in the tunica media was associated with larger aneurysms: 7.0 mm (7.0–9.0 mm) versus 5.0 mm (3.5–5 mm; p = 0.011). There was no statistically significant association between smoking and CD68 expression in the tunica media (p = 0.234) or in either the tunica media or the tunica intima (p = 0.628). There was also no statistically significant association between hemorrhagic presentation of the aneurysm and CD68 expression in the tunica media (p = 0.689) or in either the tunica media or the tunica intima (p = 0.348). Therefore, the presence of CD68-positive cells in the aneurysmal walls indicates an association with size, especially if the tunica media is exclusively compromised (p = 0.011).

Conclusion Immunohistochemistry investigation for CD68 antibodies was used to determine histiocytic infiltration. Adequately powered studies are necessary to further investigate the association between CD68-positive cells and both smoking history and hemorrhagic presentation of aneurysms.

Keywords

CD68 - brain aneurysms - smokers

Author Contributions

The study was conceived by C.U.C. and P.H.P.A. P.S.C. and M.U.C. resected the fundus of brain aneurysms. Histologic analysis was performed by E.C. Data were collected and analyzed by C.U.C., M.A.S., and A.P.T. C.U.C. and M.A.S. wrote the manuscript with input from all the co-authors.

Publication History

Received: 18 September 2022

Accepted: 14 August 2023

Accepted Manuscript online:
16 August 2023

Article published online:
19 December 2023

• References

• 1 Thompson BG, Brown Jr RD, Amin-Hanjani S. et al; American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, and Council on Epidemiology and Prevention, American Heart Association, American Stroke Association. Guidelines for the management of patients with unruptured intracranial aneurysms: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2015; 46 (08) 2368-2400
• 2 Connolly Jr ESJ, Rabinstein AA, Carhuapoma JR. et al; American Heart Association Stroke Council, Council on Cardiovascular Radiology and Intervention, Council on Cardiovascular Nursing, Council on Cardiovascular Surgery and Anesthesia, Council on Clinical Cardiology. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/american Stroke Association. Stroke 2012; 43 (06) 1711-1737
• 3 Frösen J, Piippo A, Paetau A. et al. Remodeling of saccular cerebral artery aneurysm wall is associated with rupture: histological analysis of 24 unruptured and 42 ruptured cases. Stroke 2004; 35 (10) 2287-2293
• 4 Chistiakov DA, Killingsworth MC, Myasoedova VA, Orekhov AN, Bobryshev YV. CD68/macrosialin: not just a histochemical marker. Lab Invest 2017; 97 (01) 4-13
• 5 Lucarini G, Zizzi A, Rubini C, Ciolino F, Aspriello SD. VEGF, microvessel density, and CD44 as inflammation markers in peri-implant healthy mucosa, peri-implant mucositis, and peri-implantitis: impact of age, smoking, PPD, and obesity. Inflammation 2019; 42 (02) 682-689
• 6 Bruno G, Todor R, Lewis I, Chyatte D. Vascular extracellular matrix remodeling in cerebral aneurysms. J Neurosurg 1998; 89 (03) 431-440
• 7 Morel S, Diagbouga MR, Dupuy N. et al. Correlating clinical risk factors and histological features in ruptured and unruptured human intracranial aneurysms: the Swiss AneuX Study. J Neuropathol Exp Neurol 2018; 77 (07) 555-566
• 8 Huuska N, Netti E, Lehti S, Kovanen PT, Niemelä M, Tulamo R. Lymphatic vessels are present in human saccular intracranial aneurysms. Acta Neuropathol Commun 2022; 10 (01) 130
• 9 Meng H, Tutino VM, Xiang J, Siddiqui A. High WSS or low WSS? Complex interactions of hemodynamics with intracranial aneurysm initiation, growth, and rupture: toward a unifying hypothesis. AJNR Am J Neuroradiol 2014; 35 (07) 1254-1262
• 10 Johnson BD, Mather KJ, Wallace JP. Mechanotransduction of shear in the endothelium: basic studies and clinical implications. Vasc Med 2011; 16 (05) 365-377
• 11 Kamio Y, Miyamoto T, Kimura T. et al. Roles of nicotine in the development of intracranial aneurysm rupture. Stroke 2018; 49 (10) 2445-2452
• 12 Zhou S, Dion PA, Rouleau GA. Genetics of intracranial aneurysms. Stroke 2018; 49 (03) 780-787
• 13 Grillo F, Pigozzi S, Ceriolo P, Calamaro P, Fiocca R, Mastracci L. Factors affecting immunoreactivity in long-term storage of formalin-fixed paraffin-embedded tissue sections. Histochem Cell Biol 2015; 144 (01) 93-99
• 14 Fennell VS, Kalani MYS, Atwal G, Martirosyan NL, Spetzler RF. Biology of saccular cerebral aneurysms: a review of current understanding and future directions. Front Surg 2016; 3: 43
• 15 Ollikainen E, Tulamo R, Kaitainen S. et al. Macrophage infiltration in the saccular intracranial aneurysm wall as a response to locally lysed erythrocytes that promote degeneration. J Neuropathol Exp Neurol 2018; 77 (10) 890-903
• 16 Vercellino M, Masera S, Lorenzatti M. et al. Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter. J Neuropathol Exp Neurol 2009; 68 (05) 489-502
• 17 Hokari M, Nakayama N, Nishihara H, Houkin K. Pathological findings of saccular cerebral aneurysms-impact of subintimal fibrin deposition on aneurysm rupture. Neurosurg Rev 2015; 38 (03) 531-540 , discussion 540
• 18 Shimizu K, Kushamae M, Mizutani T, Aoki T. Intracranial aneurysm as a macrophage-mediated inflammatory disease. Neurol Med Chir (Tokyo) 2019; 59 (04) 126-132
• 19 Suzuki H, Mikami T, Tamada T. et al. Inflammation promotes progression of thrombi in intracranial thrombotic aneurysms. Neurosurg Rev 2020; 43 (06) 1565-1573